SSH - PANAMA CITY INC — History
CCN 102017 | 3-year financial timeline | COVID resilience: 70/100
🛡️ Public data only — no PHI permitted on this instance.
$17M
Latest Revenue (FY2022)
+3.2%
Revenue CAGR (3yr)
35.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $16M | $18M | $17M | -1.5% | +3.2% |
| Operating Expenses | $14M | $16M | $11M | -28.9% | -12.0% |
| Operating Margin | 11.1% | 10.3% | 35.2% | +242.5% | +78.4% |
| Net Income | $2M | $2M | $6M | +237.5% | +84.1% |
| Licensed Beds | 30 | 30 | 30 | +0.0% | +0.0% |
| Total Patient Days | 8,945 | 9,270 | 9,304 | +0.4% | +2.0% |
| Medicare Day % | 61% | 49% | 53% | +8.8% | -6.9% |
| Medicaid Day % | 0% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 70/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +6.5% ($16M → $17M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.2%
This Hospital
+7.6%
State Avg
Latest Margin
35.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $18M | 47.3% |
| FY2024 (proj) | $18M | 59.4% |
| FY2025 (proj) | $19M | 71.5% |